EUR 18.38
(0.33%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 141.94 Million EUR | 9.2% |
2022 | 135.61 Million EUR | 14.0% |
2021 | 116 Million EUR | -2.95% |
2020 | 115.49 Million EUR | 3.96% |
2019 | 111.71 Million EUR | 30.42% |
2018 | 87.16 Million EUR | -4.24% |
2017 | 92.39 Million EUR | 84.87% |
2016 | 49.52 Million EUR | 133.12% |
2015 | 42.32 Million EUR | -233.13% |
2014 | 110.17 Million EUR | 36.59% |
2013 | 71.99 Million EUR | 10.1% |
2012 | 65.63 Million EUR | 17.3% |
2011 | 59.63 Million EUR | 26.22% |
2010 | 49.16 Million EUR | 14.12% |
2009 | 43.08 Million EUR | 8.22% |
2008 | 39.8 Million EUR | 7.9% |
2007 | 37.26 Million EUR | 14.57% |
2006 | 26.96 Million EUR | -3.04% |
2005 | 33.21 Million EUR | -0.44% |
2004 | 30.9 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 75.42 Million EUR | 0.0% |
2023 FY | - EUR | 9.2% |
2023 Q2 | 69.75 Million EUR | 0.0% |
2023 Q4 | 74.4 Million EUR | 0.0% |
2022 FY | - EUR | 14.0% |
2022 Q2 | 61.93 Million EUR | 0.0% |
2022 Q4 | 64.6 Million EUR | 0.0% |
2021 Q4 | 60.75 Million EUR | 0.0% |
2021 Q2 | 54.73 Million EUR | 0.0% |
2021 FY | - EUR | -2.95% |
2020 Q4 | 58.75 Million EUR | 0.0% |
2020 FY | - EUR | 3.96% |
2020 Q2 | 61.28 Million EUR | 0.0% |
2019 Q4 | 59.51 Million EUR | 0.0% |
2019 Q2 | 54.19 Million EUR | 0.0% |
2019 FY | - EUR | 30.42% |
2018 Q4 | - EUR | 0.0% |
2018 Q2 | 43.98 Million EUR | 0.0% |
2018 FY | - EUR | -4.24% |
2017 Q4 | 40.79 Million EUR | 0.0% |
2017 FY | - EUR | 84.87% |
2017 Q2 | 47.18 Million EUR | 0.0% |
2016 FY | - EUR | 133.12% |
2016 Q4 | 45.24 Million EUR | 0.0% |
2016 Q2 | 43.89 Million EUR | 0.0% |
2015 FY | - EUR | -233.13% |
2015 Q4 | 39.71 Million EUR | 0.0% |
2015 Q2 | 55.42 Million EUR | 0.0% |
2014 Q4 | 54.73 Million EUR | 0.0% |
2014 FY | - EUR | 36.59% |
2014 Q2 | 53.15 Million EUR | 0.0% |
2013 Q4 | 40.05 Million EUR | 0.0% |
2013 FY | - EUR | 10.1% |
2013 Q2 | 34.4 Million EUR | 0.0% |
2012 Q4 | - EUR | 0.0% |
2012 FY | - EUR | 17.3% |
2012 Q2 | - EUR | 0.0% |
2011 FY | - EUR | 26.22% |
2011 Q2 | - EUR | 0.0% |
2010 Q4 | - EUR | 0.0% |
2010 FY | - EUR | 14.12% |
2010 Q2 | - EUR | 0.0% |
2009 FY | - EUR | 8.22% |
2009 Q4 | - EUR | 0.0% |
2008 FY | - EUR | 7.9% |
2007 FY | - EUR | 14.57% |
2006 FY | - EUR | -3.04% |
2005 FY | - EUR | -0.44% |
2004 FY | - EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
AB Science S.A. | -9.28 Million EUR | 1629.426% |
Boiron SA | 80.67 Million EUR | -75.939% |
Ipsen S.A. | 1.14 Billion EUR | 87.581% |
Malin Corporation plc | -3.8 Million EUR | 3835.421% |
Vetoquinol SA | 104.58 Million EUR | -35.728% |